ARCA biopharma, Inc. - COM (ABIO)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
7.2 M
Holdings value Q1 2024
$12.7 M
Value change Q1 2024
-$474 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
21
Number of buys Q1 2024
7
Number of sells Q1 2024
-8
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
00211Y506
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 7.2 M $12.7 M -$474 K $1.76 21
2023 Q4 7.48 M $12.7 M +$358 K $1.70 24
2023 Q3 3.26 M $6.55 M +$923 K $2.01 22
2023 Q2 2.83 M $5.75 M +$627 K $2.03 23
2023 Q1 2.52 M $5.02 M -$188 K $1.99 26
2022 Q4 2.61 M $6.19 M -$937 K $2.36 22
2022 Q3 2.19 M $4.52 M +$1.12 M $2.06 21
2022 Q2 1.68 M $4.17 M +$1.36 M $2.49 20
2022 Q1 1.08 M $2.48 M +$14.4 K $2.30 18
2021 Q4 1.12 M $2.41 M -$1.26 M $2.15 15
2021 Q3 1.53 M $4.53 M +$975 K $2.96 15
2021 Q2 1.14 M $3.98 M +$974 K $3.49 12
2021 Q1 876 K $3.2 M +$70.8 K $3.65 14
2020 Q4 821 K $3.29 M +$1.62 M $4.00 14
2020 Q3 412 K $1.82 M +$1.17 M $4.41 8
2020 Q2 136 K $898 K -$419 K $6.62 3
2020 Q1 201 K $560 K -$65 K $2.80 4
2019 Q4 211 K $1.2 M +$327 K $5.69 6
2019 Q2 272 K $1.96 M +$1.96 M $7.32 7